SOX2 and neoplasm: It is therefore possible that by manipulating SOX2 oscillations to sustained expression we can prevent quiescent GSCs from reactivating, thus prohibiting tumour progression, specifically after traditional chemotherapy where the active proliferative part of the tumour has been largely eliminated, while quiescent GSCs persist.